The relationship between arteriovenous fistula success and inflammation

References

• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:17–31
   Google Scholar
• Allon M, Daugirdas J, Depner TA, Greene T, Ornt D, Schwab SJ. Effect of change vascular Access on patient mortality in hemodialysis patients. Am J Kidney Dis. 2006;47:469–477
   Google Scholar
• Pastan S, Soucie M, McClellan WM. Vascular acess and increased risk of death among hemodialysis patients. Kidney Int. 2002;62:620–626
   PubMed Web of Science ®Google Scholar
• Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A. Factors associated with early failure of arteriovenous fistulae for hemodialysis access. Eur J Vasc Endovasc Surg. 1996;12:207–213
   PubMed Web of Science ®Google Scholar
• Kim YO, Yoon SA, Kim YS, et al. Early dysfunction of radiocephalic arteriovenous fistula: primary and secondary patency rate of percutaneous angioplasty. Korean J Nephrol. 2003;22:414–419
   Google Scholar
• Kim YO. Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. Korean J Nephrol. 2006;25:S559–S562
   Google Scholar
• Gimdt M, Heine GH, Ulrich C, Kohler H. Gene polymorphism association studies in dialysis: vascular access. Semin Dial. 2007;20:63–67
   Google Scholar
• Owen WF, Lowrie EG. C-reactive protein as an outcome predictor for maintanence hemodialysis patients. Kidney Int. 1998;54:627–636
   PubMed Web of Science ®Google Scholar
• Kaysen GA, Stevenson FT, Depner TA. Determinants of albumin concentration in hemodialysis patients. Am J Kidney Dis. 1997;29:658–668
   PubMed Web of Science ®Google Scholar
• Gunnell J, Yeun JY, Depner TA, Kaysen GA. Acute-phase response predicts erythropoietin resistance in hemodialysis patients. Am J Kidney Dis. 1999;33:63–72
   PubMed Web of Science ®Google Scholar
• Tekin IO, Pocan B, Borazan A, et al. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients. Ren Fail. 2008;30:219–225
   PubMed Web of Science ®Google Scholar
• Murphy SW, Foley RN, Parfey PJ. National kidney foundation task force on cardiovascular disease: screening and treatment for cardiovascular disease in patients with chronic renal disease. Am J Kidney Dis. 1998;32:184–199
   Google Scholar
• Third NKF-K/DOQI Clinical Practice Guidelines for vascular Access: update 2000. Am J Kidney Dis. 2001;37(suppl 1):S137–S181
   PubMed Web of Science ®Google Scholar
• Speidl WS, Graf S, Hornykewycz S. High-sensitivity c-reactive protein in the prediction of coronary events in patients with premature coranary artery disease. Am Heart J. 2002;144: 449–455
   PubMed Web of Science ®Google Scholar
• Ridker PM, Stampfer MJ, Rifai N. Novel risk for systemic aterosclerosis. J Am Med Assoc. 2001;286:2401–2402
   Google Scholar
• Qureshi AR, Alvestrand A, Divino-Filho JC, et al. Elevated serum CRP is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients. J Am Soc Nephrol. 1995;6:573–581
   Google Scholar
• Borazan A, Ustün H, Ustundag Y, et al. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactiveprotein levels. Mediators Inflamm. 2004;13:201–204
   PubMed Web of Science ®Google Scholar
• Wanner C, Metzger T. C-reactive protein a marker for all-cause and cardiovascular mortalitiy in hemodialysis patients. Nephrol Dial Transplant. 2002;17:29–32
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Heimbürger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899–1911
   PubMed Web of Science ®Google Scholar
• Kronenberg F. Homocysteine, lipoprotein (a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease. Curr Opin Nephrol Hypertens. 1998;7:271–278
   PubMed Web of Science ®Google Scholar
• Culp K, Flanigan M, Taylar L, Rothstein M. Vascular access thrombosis in new hemodialysis patients. Am J Kidney Dis. 1995;26:341–346
   PubMedGoogle Scholar
• Paszkowiak JJ, Dardik A. Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg. 2003;37:47–57
   PubMedGoogle Scholar
• Meyerson SL, Skelly CL, Curi MA, et al. The effects of extremely low shear stress on cellular proliferation and neointimal thickening in the failing bypass graft. J Vasc Surg. 2001;34:90–97
   Google Scholar
• Morena M, Bosc JY, Jaussent I, et al. The role of mineral metabolism and inflammation on dialysis vascular access failure. Vasc Access. 2006;7:77–82
   Google Scholar
• Wali MA, Eid RA, Dewan M, Al-Homrany AM. Pre-existing histopathological changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction. Ann Thorac Cardiovasc Surg. 2006;12:341–348
   PubMedGoogle Scholar